Is mouse embryonic stem cell technology obsolete? by unknown
Skarnes Genome Biology  (2015) 16:109 
DOI 10.1186/s13059-015-0673-6RESEARCH HIGHLIGHT Open AccessIs mouse embryonic stem cell technology
obsolete?
William C SkarnesAbstract
Injection of recombinant Cas9 protein and synthetic
guide RNAs into mouse zygotes has been shown to
facilitate gene disruption and knock-ins using the
CRISPR system. These technologies may soon displace
genetic modification using embryonic stem cells.jections of modified ES cells in to pre-implantation em-
bryos, with no assurance that the genetic modification willGenetic engineering of the mouse
Since the discovery of mouse embryonic stem (ES) cells
more than 25 years ago, researchers have exploited their
properties to engineer increasingly sophisticated genetic
alterations with nucleotide precision. Mouse ES cells are
highly amenable to genetic modification because of their
rapid growth rate, ease of DNA transfection, and clon-
ability. High rates of homologous recombination bet-
ween an exogenous donor vector and the endogenous
genome are routinely achieved in mouse ES cells; they
are highest when linear isogenic constructs are used,
with long homology arms and cassettes for positive and
negative selection. Over the years, incremental improve-
ments in gene-targeting vector design have made it pos-
sible to engineer mice carrying virtually any desired
genetic modification, from a single base-pair change
to the replacement of megabase-sized regions of the
genome. Mouse ES cell technology embodies the most
sophisticated forms of genome engineering practiced yet,
culminating, for example, in genome-scale conditional
knockout resources for the functional annotation of
mammalian genes [1] and the humanization of the
mouse immunoglobulin genes [2]. But the pre-eminence
of mouse ES cells is now being challenged by technology
involving clustered regularly interspaced short palin-
dromic repeats (CRISPR) and the associated endonucle-
ase Cas9 that enables genetic engineering of mouse
embryos directly [3, 4]. In a recent paper in GenomeCorrespondence: skarnes@sanger.ac.uk
Stem Cell Engineering, Wellcome Trust Sanger Institute, Wellcome Trust
Genome Campus, Hinxton, Cambridge CB10 1SA, UK
© 2015 Skarnes; licensee BioMed Central. This
Attribution License (http://creativecommons.o
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Biology, Kohichi Tanaka and colleagues [5] describe an
improved CRISPR-Cas method for efficient editing of
mouse embryos by homologous recombination.
One significant drawback of mouse ES cell technology
is the time and effort required to produce genetically
modified mice from ES cells. At least 6 months is required
to produce and breed ES-cell-derived chimeras from in-
be transmitted to their offspring. Not all ES cell lines are
robust, especially those derived from inbred mice other
than the 129 strain, and often multiple independent tar-
geted clones must be injected to produce mice. Genome
instability of cultured ES cells is one reason for failure of
germline transmission, overtly manifested by the loss or
gain of whole chromosomes in culture. Regional copy
number changes are also common in cultured ES cells [6]
and are of particular concern if small sequence gains or
losses are transmitted to offspring. In practice, germline
transmission of more than one independent ES cell clone
is required to establish a causal link between a genetic
alteration and the phenotype observed in mice. Despite
these difficulties, more than 25,000 genetically modified
mouse strains have so far been produced from ES cells, in-
cluding knockouts of about half the protein coding genes
in mice.Nuclease-assisted targeting
Soon after gene targeting was established in mouse ES
cells, researchers began to ask if homologous recombi-
nation was possible in one-cell embryos. Only one group
managed to produce a single recombinant mouse from
pronuclear injections of more than 10,000 embryos [7].
Clearly, the rate of homologous recombination in fer-
tilized eggs was too low to provide a viable alternative to
ES cell technology. Around the same time, experiments
in mouse ES cells by Maria Jasin and colleagues [8]
showed that gene targeting with a homologous donor
plasmid is increased at least 50-fold by inducing a double-
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gous recombination were often associated with small
insertions or deletions characteristic of error-prone non-
homologous end joining (NHEJ). These pioneering expe-
riments would lay the foundation for genome editing of
mouse embryos following the advent of programmable
site-specific nucleases, initially using zinc finger nucleases
[9] and more recently CRISPR-Cas9 nucleases [3, 4].
Researchers have embraced CRISPR-Cas9 to generate
rudimentary alleles in mouse zygotes and other model
species. Simple insertions/deletions induced by NHEJ or
the incorporation of single strand oligonucleotides by
homology-directed repair are now routinely carried out
by transgenic facilities. However, more complex alleles
that require homologous recombination with a donor
plasmid [4, 9] are more difficult to produce by zygote in-
jection. Typically, only a few percent of injected embryos
co-injected with a nuclease and a donor plasmid carry
the desired targeted modification. Because the founder
animals are often mosaic, transmission of the targeted
allele to the next generation is not guaranteed. Thus,
further improvement of Cas9-assisted targeting in mouse
zygotes is required to rival the broad range of genetic
modifications possible in mouse ES cells.
Cloning-free CRISPR-Cas9
The standard method for co-delivery of Cas9 endonu-
clease and a donor plasmid is to inject a mixture of the
donor plasmid, Cas9 mRNA, and guide RNA into the
cytoplasm and/or pronucleus of the fertilized egg [4]. Al-
ternatively, pronuclear injection of recombinant Cas9
protein in complex with guide RNA also proved to be
very effective in generating simple knockouts in mouse
and zebrafish [10]. Based on delivery of Cas9 ribonu-
cleoprotein (RNP), Aida et al. [5] have now developed a
highly efficient method for the production of knock-in
alleles in mice. Injections of Cas9 RNP and a donor plas-
mid encoding green fluorescent protein (GFP) into the
pronucleus of one-cell embryos resulted in correct ho-
mologous recombination in 5 of 11 founder animals. In
contrast, only one of eight founders carried the correctly
targeted allele from injections of standard Cas9 mRNA,
guide RNA and donor plasmid. Interestingly, chemically
synthesized dual guide RNAs (CRISPR RNA and trans-
activating CRISPR RNA) seem to be more effective than
in vitro transcribed single guide RNA, although no dif-
ference in Cas9 endonuclease activity was observed in
an in vitro digestion assay. This finding suggests the as-
sembly of active Cas9 ribonucleoprotein complexes in
the embryo is not optimal using in vitro transcribed
single guide RNA and merits further investigation.
Several advantages of using Cas9 ribonucleoprotein
are highlighted in the study by Aida et al. [5]. First,
the observed increase in homologous recombinationefficiency is probably due to the fact that Cas9 protein
complexes are immediately active. When delivered to
the nucleus with a donor plasmid, Cas9 ribonucleopro-
tein promotes homologous recombination at the target
site without delay. Second, embryos are exposed to high
Cas9 activity for a short period of time, reducing the
likelihood of mosaicism and off-target damage. Indeed,
no detectable damage at predicted off-target sites was
observed in founder animals and, consistent with non-
mosaic inheritance, 50 % of their offspring carried the
targeted allele. From a practical standpoint, the use of
synthetic guide RNAs is very convenient, eliminating the
need to clone and purify in vitro transcribed single guide
RNA. The high rate of homologous recombination ob-
served in founder animals using recombinant Cas9 pro-
tein and synthetic guide RNAs [5] is very encouraging.
More studies are now needed to determine if this
method is generalizable to other loci and other verte-
brate species.
The remarkable rise of nuclease-assisted genome edi-
ting signals a revolution in genetic engineering that is
applicable to any model species or cell. The CRISPR-Cas
system, in particular, is simple to use and the reagents
for modifying embryos and cells can now be purchased
from commercial suppliers. We can expect continued
improvements in the quality of these reagents and
methods for their delivery. Lingering concerns about the
specificity of Cas9 endonuclease are falling away with
each report that documents little or no off-target dam-
age in founder animals. In comparison with the genome
instability observed in cultured ES cells (an issue never
satisfactorily resolved with respect to ES-cell-derived
models), CRISPR-Cas technology is relatively safe. The
study by Aida et al. [5] shows that Cas9-assisted tar-
geting is very efficient in mouse embryos and will enable
the engineering of complex alleles. Thus, the end of
mouse ES cell technology now seems inevitable.
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